Stereotactic Prostate Radiation Therapy with Simultaneous Moderate Dose Escalation to the Dominant Intraprostatic Lesion: A Dosimetric Study

被引：0
|
作者：
Yu, S. [1 ]
Mathew, J. [1 ]
Dyer, M. [1 ]
Bloch, B. N. [1 ]
Hirsch, A. E. [1 ]
机构：
[1] Boston Univ, Med Ctr, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.733
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3815
引用
收藏
页码：E777 / E778
页数：2
相关论文
共 50 条
  • [1] Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
    Kim, Yeon Joo
    Yoon, Kyoung Jun
    Kim, Young Seok
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
    Yeon Joo Kim
    Kyoung Jun Yoon
    Young Seok Kim
    Scientific Reports, 10
  • [3] MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost to Dominant Intraprostatic Lesions for Prostate Cancer: A Retrospective Dosimetric Study
    Du, D.
    Lee, J.
    Pantelic, M.
    Hurst, N.
    Movsas, B.
    Chetty, I.
    Wen, N.
    MEDICAL PHYSICS, 2019, 46 (06) : E268 - E268
  • [4] DOES DOSE ESCALATION TO A DOMINANT INTRAPROSTATIC LESION IN A PERMANENT IMPLANT INCREASE PROSTATE DOSE PARAMETERS?
    Gaudet, M.
    Vigneault, E.
    Aubin, S.
    Varfalvy, N.
    Harel, F.
    Beaulieu, L.
    Martin, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S35 - S35
  • [5] SIMULTANEOUS INTEGRATED BOOST WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR DOMINANT INTRAPROSTATIC LESION IN LOW-INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A DOSE ESCALATION TRIAL
    Bonome, Paolo
    Macchia, Gabriella
    Ferro, Milena
    Cilla, Savino
    Romano, Carmela
    Re, Alessia
    Pezzulla, Donato
    Picardi, Vincenzo
    Ferro, Marica
    Boccardi, Mariangela
    Cammelli, Silvia
    Buwenge, Milly
    Tagliaferri, Luca
    Iezzi, Roberto
    Morganti, Alessio Giuseppe
    Valentini, Vincenzo
    Deodato, Francesco
    ANTICANCER RESEARCH, 2021, 41 (10) : 5323 - 5324
  • [6] Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
    Zhou, Jun
    Yang, Xiaofeng
    Chang, Chih-Wei
    Tian, Sibo
    Wang, Tonghe
    Lin, Liyong
    Wang, Yinan
    Janopaul-Naylor, James Robert
    Patel, Pretesh
    Demoor, John D.
    Bohannon, Duncan
    Stanforth, Alex
    Eaton, Bree
    McDonald, Mark W.
    Liu, Tian
    Patel, Sagar Anil
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (01)
  • [7] A Computational model for predicting dose escalation to the dominant intraprostatic lesion during high dose rate prostate brachytherapy
    Wronski, Matt
    Ravi, Ananth
    Davidson, Melanie
    Loblaw, Andrew
    Morton, Gerard
    Chung, Hans
    Tseng, Chia-Lin
    Mendez, Lucas
    Paudel, Moti
    MEDICAL PHYSICS, 2017, 44 (08) : 4399 - 4400
  • [8] Dose escalation in dominant intraprostatic lesion with MRI-guided HDR brachytherapy in localized prostate cancer
    Mascarenhas, F.
    Marques, F.
    Germano, S.
    Faustino, S.
    Miguel, C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S563 - S564
  • [9] Prediction of Dosimetric Variation in Dominant Intraprostatic Lesion with Simultaneous Integrated Boost for Pencil Beam Proton Therapy
    Chang, C.
    Bohannon, D.
    Stiles, K.
    Stanforth, A.
    Tian, S.
    Wang, Y.
    Lin, L.
    Patel, P.
    Liu, T.
    Yang, X.
    Zhou, J.
    MEDICAL PHYSICS, 2020, 47 (06) : E434 - E434
  • [10] Dose-Escalation for a Dominant Intraprostatic Lesion Using a Combination of IMRT and VMAT
    Abdellatif, A.
    Hoover, D.
    Craig, J.
    Mosalaei, H.
    Mulligan, M.
    Bzdusek, K.
    Bauman, G.
    Chen, J.
    Wong, E.
    MEDICAL PHYSICS, 2010, 37 (06)
12345